Medical Devices

MiMedx Group Reveals Robust Q4 2025 Results Amidst Strategic Growth Initiatives

Stock market news /

$MDXG Reports Strong Q4 2025 Performance, Exceeding Revenue Forecasts Key Takeaways MiMedx Group, Inc. (MDXG) reported Q4 2025 revenue of $110.3 million, marking a significant 15.2% increase year-over-year, surpassing analyst consensus, per Q4 2025 Earnings Call Transcript. Net income for the quarter reached $12.5 million, translating to $0.09 per diluted share, demonstrating improved profitability and […]

MiMedx Group Reveals Robust Q4 2025 Results Amidst Strategic Growth Initiatives Read More »

$SIBN Reports Strong Q4 2025 Revenue Growth, Exceeding Expectations

Stock market news /

Key Takeaways Q4 2025 revenue reached $125.7 million, a 22% year-over-year increase, surpassing analyst consensus of $120 million, per the earnings call transcript. Non-GAAP gross margin improved to 82.5% in Q4 2025, up from 80.1% in the prior year period, according to the company’s financial statements discussed during the call. SI-BONE issued full-year 2026 revenue

$SIBN Reports Strong Q4 2025 Revenue Growth, Exceeding Expectations Read More »